- Home
- MCRB vs RMBI Comparison
MCRB vs RMBI Comparison
Compare MCRB & RMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- RMBI
- Stock Information
- Founded
- MCRB 2010
- RMBI 1887
- Country
- MCRB United States
- RMBI United States
- Employees
- MCRB N/A
- RMBI N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- RMBI Major Banks
- Sector
- MCRB Health Care
- RMBI Finance
- Exchange
- MCRB Nasdaq
- RMBI Nasdaq
- Market Cap
- MCRB 125.7M
- RMBI 139.0M
- IPO Year
- MCRB 2015
- RMBI 2019
- Fundamental
- Price
- MCRB $13.99
- RMBI $13.51
- Analyst Decision
- MCRB Hold
- RMBI
- Analyst Count
- MCRB 4
- RMBI 0
- Target Price
- MCRB $73.67
- RMBI N/A
- AVG Volume (30 Days)
- MCRB 148.0K
- RMBI 29.1K
- Earning Date
- MCRB 08-06-2025
- RMBI 07-23-2025
- Dividend Yield
- MCRB N/A
- RMBI 4.34%
- EPS Growth
- MCRB N/A
- RMBI 17.64
- EPS
- MCRB 8.98
- RMBI 0.95
- Revenue
- MCRB N/A
- RMBI $43,441,048.00
- Revenue This Year
- MCRB N/A
- RMBI N/A
- Revenue Next Year
- MCRB N/A
- RMBI N/A
- P/E Ratio
- MCRB $1.53
- RMBI $14.56
- Revenue Growth
- MCRB N/A
- RMBI 4.33
- 52 Week Low
- MCRB $6.53
- RMBI $11.37
- 52 Week High
- MCRB $27.40
- RMBI $15.15
- Technical
- Relative Strength Index (RSI)
- MCRB 58.12
- RMBI 43.31
- Support Level
- MCRB $12.15
- RMBI $13.82
- Resistance Level
- MCRB $15.40
- RMBI $13.98
- Average True Range (ATR)
- MCRB 1.36
- RMBI 0.45
- MACD
- MCRB -0.12
- RMBI -0.04
- Stochastic Oscillator
- MCRB 65.29
- RMBI 23.08
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.